Skip to main content

Table 1 Correlations between circNFIX expression and clinical characteristics in glioma patients

From: CircNFIX promotes progression of glioma through regulating miR-378e/RPN2 axis

Clinicopathologic featuresN (%)Relative CircNFIX levelP value
High (%)Low (%)
Total cases64 (100.0)36 (56.3)28 (43.7) 
Age (years)0.7647
  ≥ 4540 (62.5)22 (55.0)18 (45.0) 
  < 4524 (37.5)14 (58.3)10 (41.7)
Gender0.4363
 Male37 (57.8)20 (54.1)17 (45.9) 
 Female27 (42.2)16 (59.3)9 (40.7)
WHO grade0.0177
 I-II26 (40.6)10 (38.5)16 (61.5) 
 III-IV38 (59.4)26 (68.4)12 (31.6)
Tumor size (cm)0.0262
  ≥ 336 (56.3)23 (63.9)13 (36.1) 
  < 328 (43.7)13 (46.4)15 (53.6)
Tumor location0.5239
 Supratentorial43 (67.2)23 (53.5)20 (46.5) 
 Subtentorial21 (32.8)13 (61.9)8 (38.1)